Grooteman, K. V., van Geenen, E. J. M., & Drenth, J. P. H. (2016). Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: A protocol of the OCEAN trial. BMJ Open.
Citação norma ChicagoGrooteman, K V., E J M. van Geenen, and J P H. Drenth. "Multicentre, Open-label, Randomised, Parallel-group, Superiority Study to Compare the Efficacy of Octreotide Therapy 40 mg Monthly Versus Standard of Care in Patients With Refractory Anaemia Due to Gastrointestinal Bleeding From Small Bowel Angiodysplasias: A Protocol of the OCEAN Trial." BMJ Open 2016.
Citação norma MLAGrooteman, K V., E J M. van Geenen, and J P H. Drenth. "Multicentre, Open-label, Randomised, Parallel-group, Superiority Study to Compare the Efficacy of Octreotide Therapy 40 mg Monthly Versus Standard of Care in Patients With Refractory Anaemia Due to Gastrointestinal Bleeding From Small Bowel Angiodysplasias: A Protocol of the OCEAN Trial." BMJ Open 2016.